Be Bio
Viera Muzithras has extensive experience in regulatory affairs, currently serving as Vice President at Be Biopharma since July 2023. Previously, Viera held the position of Vice President at TCR² Therapeutics Inc. from May 2020 to July 2023 and worked at Celgene in a regulatory affairs role from July 2016 to May 2020. Viera's career includes significant positions at Novartis as Senior Director of Regulatory Affairs, Bayer HealthCare, sanofi-aventis, Pfizer, and Lederle/Wyeth, demonstrating a long-standing commitment to regulatory matters within the biopharmaceutical industry.
This person is not in any teams
This person is not in any offices
Be Bio
Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.